Brain+ informs of progress on its UK focused proof-of-business strategy plan
Copenhagen, Denmark, 16 May 2024 – Brain+ A/S (Nasdaq First North: BRAINP)
· Supportive early user feedback from the ongoing AgeUK usability study of the CST-Assistant v2.0 to standardize Cognitive Stimulation Therapy (CST)
· Application submitted for the CST-Assistant to be included on G-Cloud, the digital procurement platform for the UK National Health Service, NHS
· Development and UK regulatory compliance of the English CST-Assistant v2.0 as medical software advancing as planned towards UK launch in Q3 2023
· Together with Quiddity, pre-commercial outreach to relevant